Ursodeoxycholic Acid Market |
Ursodeoxycholic acid refers to a bile acid that supports the liver and digestive health. It is usually prescribed to patients suffering from cholesterol gallstones and certain liver diseases. Ursodeoxycholic acid helps in dissolving and removing cholesterol gallstones from the gallbladder and improve liver function by replacing other more harmful bile acids.
The global Ursodeoxycholic Acid Market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Growing popularity of digital fitness apps utilizing features like diet and nutrition tracking, sleep monitoring and medication reminders is fueling demand for nutrition supplements like ursodeoxycholic acid for liver health support. Fitness apps enable people to track their medical conditions at their convenience from anywhere. With rising health awareness and preventive healthcare approach, more number of individuals are adopting digital health technologies to maintain overall wellbeing which is contributing to the growth of the ursodeoxycholic acid market.
Segment Analysis:
The global ursodeoxycholic acid market is segmented by application into gallstone dissolution, primary sclerosis cholangitis, and others. The gallstone dissolution segment dominates the market and accounted for the largest revenue share in 2023. Ursodeoxycholic acid is the most common treatment for gallstone dissolution as it helps dissolve small or medium-sized gallstones.
Key Takeaways:
The Global Ursodeoxycholic Acid Market Size is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing cases of gallstone disease and liver disorders across the globe.
Regional analysis
North America dominated the global market in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to increasing expenditure on healthcare services and high awareness regarding UDCA treatment in the region. The Asia Pacific region is expected to witness the fastest growth rate over the forecast period due to improving healthcare infrastructure and rapid economic development.
Key players
Key players operating in the ursodeoxycholic acid market are PharmaZell, ABIL CHEMPHARMA PRIVATE LIMITED, ICE, Grindeks, Suzhou Tianlu Bio-pharmaceutical Co.,Ltd, ARCELOR CHEMICALS PRIVATE LIMITED. PharmaZell is a leading player due to its wide distribution channel for UDCA products globally.
Explore more trending article on this topic -
https://www.insightprobing.com/ursodeoxycholic-acid-market-share-and-demand-analysis/
Comments
Post a Comment